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Abstract
Background: The vaginal microbiota can impact the susceptibility of women to bacterial vaginosis (BV) and sexually
transmitted infections (STIs). BV is characterized by depletion of Lactobacillus spp., an overgrowth of anaerobes (often
dominated by Gardnerella vaginalis) and a pH > 4.5. BV is associated with an increased risk of acquiring STIs such as
chlamydia and gonorrhea. While these associations have been identified, the molecular mechanism(s) driving the risk
of infections are unknown. An ex vivo porcine vaginal mucosal model (PVM) was developed to explore the mechanistic
role of Lactobacillus spp. in affecting colonization by G. vaginalis and Neisseria gonorrhoeae.
Results: The data presented here demonstrate that all organisms tested can colonize and grow on PVM to clinically
relevant densities. Additionally, G. vaginalis and N. gonorrhoeae form biofilms on PVM. It was observed that lactic acid,
acetic acid, and hydrochloric acid inhibit the growth of G. vaginalis on PVM in a pH-dependent manner. N. gonorrhoeae
grows best in the presence of lactic acid at pH 5.5, but did not grow well at this pH in the presence of acetic acid.
Finally, a clinical Lactobacillus crispatus isolate (24-9-7) produces lactic acid and inhibits growth of both G. vaginalis and
N. gonorrhoeae on PVM.
Conclusions: These data reveal differences in the effects of pH, various acids and L. crispatus on the growth of G.
vaginalis and N. gonorrhoeae on a live vaginal mucosal surface. The PVM is a useful model for studying the interactions
of commensal vaginal microbes with pathogens and the mechanisms of biofilm formation on the vaginal mucosa.
Keywords: Lactobacillus, Vaginal explants, Bacterial vaginosis, Microbiota, Sexually transmitted infections, Vaginal
mucosa, Biofilm
Background
Sexually transmitted infections (STIs) are a worldwide
public health problem accounting for over 1 million newly
acquired infections every day (World Health Organization).
The two most commonly reported bacterial STIs in the
United States are chlamydia (caused by Chlamydia
trachomatis) and gonorrhea (caused by Neisseria
gonorrhoeae) (Centers for Disease Control). If left
untreated, these STIs cause significant health risks
such as pelvic inflammatory disease (PID) in women,
which can lead to infertility, chronic pelvic pain and
ectopic pregnancy [1]. Bacterial vaginosis (BV) is the
most common vaginal condition reported by women
and evidence suggests that this condition can also be
sexually transmitted [2, 3]. BV is associated with preterm
birth, endometritis and increased risk of acquisition and
transmission of STIs, including C. trachomatis, N.
gonorrhoeae, and HIV [4–9]. While BV is a complex
disorder thought to arise from the overgrowth of a
wide array of anaerobes [10–12] and a decreased propor-
tion of Lactobacillus spp. [13], Gardnerella vaginalis often
predominates during BV and is thought to form a biofilm
that is associated with BV recurrence [14, 15].
* Correspondence: peter377@umn.edu
1Department of Experimental and Clinical Pharmacology, College of
Pharmacy, University of Minnesota, 4-442 McGuire Translational Research
Facility, 2001 6th St. SE, Minneapolis, MN 55455, USA
Full list of author information is available at the end of the article
© 2015 Breshears et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Breshears et al. BMC Microbiology  (2015) 15:276 
DOI 10.1186/s12866-015-0608-0
The constituents of the vaginal microbiota can affect
susceptibility to STIs, though little is known about the
molecular mechanisms at work in these interactions. In
particular, women with Lactobacillus-dominated vaginal
microbiota are at lower risk of contracting N. gonorrhoeae
and other STIs [16–19]. Lactobacillus spp. inhibit growth
of N. gonorrhoeae in vitro, and inhibitory strains are more
prevalent in women not infected with gonorrhea [20].
Depending on growth conditions, Lactobacillus spp. in-
hibit N. gonorrhoeae and G. vaginalis, through production
of hydrogen peroxide (H2O2), lactic acid and/or secreted
proteins [17, 21–28]. It is unlikely though that H2O2 plays
a major role in vivo as physiological concentrations are
below that required for inhibition of BV-associated bacter-
ial growth [26]. The majority of investigations into the
interactions of Lactobacillus spp. with N. gonorrhoeae and
G. vaginalis have been performed in vitro. While this work
has provided valuable insights into these interactions,
more complex models are required to expand our know-
ledge of how vaginal Lactobacillus spp. influence pathogen
attachment, growth and virulence in the female repro-
ductive tract.
While mouse models of both N. gonorrhoeae and G.
vaginalis infection have been developed, these models
are limited by the fact that the mouse vaginal epithelium
in keratinized (unlike the squamous epithelium of the
human vaginal epithelium), and that the resident mouse
microbiota has been somewhat characterized and is not
similar to that of humans [29]. Further, the mouse vaginal
pH, which is thought to be a critical factor in STI protec-
tion, is higher than that of humans and it is unclear how
well results in mice extrapolate to humans [30–33]. Mice
are also relatively expensive and low throughput. Our lim-
ited understanding of vaginal microbial interactions with
one another and with host mucosa highlight the need for a
new model that will allow these questions to be addressed
in a biologically complex and defined environment.
Porcine vaginal mucosa (PVM) may represent a novel
model for STI interactions with the resident microbiota
and the host mucosal surface. PVM is an excellent
model of the human vagina. As in humans, PVM is
composed of a stratified, squamous epithelium with a
similar surface lipid composition and underlying resi-
dent immune infiltrate [34]. PVM is also similar to the
human vagina in pH and permeability characteristics.
An ex vivo PVM model has been used extensively to
study the interactions of Staphylococcus aureus and its
virulence factors with the host mucosa, as well as to
investigate biofilm formation and antimicrobial efficacy
[35–46]. The similarity of PVM to the human vaginal
mucosa, and its demonstrated use as a model for
pathogen/host interactions and biofilm formation make
it an excellent candidate for similar investigations with
STI pathogens.
In the current study, the ex vivo PVM tissue model was
used to explore the role of cervicovaginal Lactobacillus
spp. in affecting colonization and growth of G. vaginalis
and N. gonorrhoeae. It was hypothesized that human
clinical isolates of Lactobacillus spp., G. vaginalis and N.
gonorrhoeae can colonize and grow on ex vivo PVM, form
biofilm (G. vaginalis and N. gonorrhoeae), and that inter-
actions of these organisms could be investigated using the
PVM model. The data presented support these hypotheses
and demonstrate a clear role for pH and Lactobacillus in
inhibition of pathogen growth on live vaginal mucosa.
Results
Human clinical isolates grow and form biofilm on PVM
The PVM is obtained as relatively large specimens
(~12 x 6 cm), from which 5 mm biopsies are taken
and trimmed to produce mucosal explants (Fig. 1a)
[37]. To determine if human clinical bacterial isolates can
grow on PVM, explants were inoculated with ~104 CFU/
explant of Lactobacillus spp., G. vaginalis, and N. gonor-
rhoeae. L. crispatus consistently grew 2 to 3 logs, exhibiting
peak growth at 48 h post-inoculation with ~ 2.6 x 106 CFU/
explant (~1.0 x 107 CFU/ml) (Fig. 1b). L. iners, L. jensenii,
and L. gasseri also showed maximal growth at 48 – 72 h
with ~107 CFU/explant, but they were not used for further
experiments in the current study (data not shown). G. vagi-
nalis grew to ~ 3.4 x 107 CFU/explant (~1.3 x 108 CFU/ml)
with peak growth at 48 – 72 h (Fig. 1c). N. gonorrhoeae
grew to ~ 1.1 x 107 CFU/explant (~4.2 x 107 CFU/ml) with
peak growth at 24 – 48 h (Fig. 1d). It should be noted that
N. gonorrhoeae grew best on the PVM when the underlying
media was at pH 5.5 – 6.5 (see below). All N. gonorrhoeae
experiments were performed under aerobic conditions, as
N. gonorrhoeae did not grow on PVM anaerobically with
RPMI as the underlying media. All other organisms were
grown on PVM anaerobically.
N. gonorrhoeae can form a biofilm in continuous-flow
chambers and on human cervical epithelial cells, suggest-
ing that biofilm formation in vivo may play a role in
pathogenesis [47, 48]. Similarly, G. vaginalis can form a
biofilm in vitro and in vivo that might contribute to the
resistance of BV to standard treatments [49–52]. The abil-
ity of N. gonorrhoeae and G. vaginalis to form biofilm on
PVM was assessed in order to determine if the PVM
model can be used to study the mechanisms of biofilm
formation. A LIVE/DEAD stain was used with confocal
microscopy to visualize both biofilm development and the
health of PVM epithelium. By 24 h post-inoculation, sin-
gle and microcolonies of adherent bacteria were observed
on PVM explants colonized with G. vaginalis (Fig. 2e).
Where these colonies were observed, the underlying epi-
thelium showed a mix of live (green) and dead (red) cells,
whereas on areas of tissue that did not show bacterial
colonization, the epithelium appeared mostly green as in
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the uninfected controls (Fig. 2a). By 48 h, patchy G. vagi-
nalis biofilm was observed that thickened and colonized
more of the surface area of the tissue over time (Fig. 2f-h).
For these large areas of biofilm the underlying epithelium
was either completely degraded or composed of dead cells
(red). PVM colonized with N. gonorrhoeae exhibited ro-
bust biofilm development within 24 h (Fig. 2m) when
compared to uninfected controls (Fig. 2i). By 48 h post-
inoculation, N. gonorrhoeae formed a thick biofilm cover-
ing most of the surface of the explants (Fig. 2n-p). Control
tissue remained healthy and uninfected over the course of
the experiment (Fig. 2i-l). Unlike the epithelial toxicity ob-
served with G. vaginalis biofilm, epithelial cells that could
be seen between patches of N. gonorrhoeae biofilm were
mostly green indicating that they were alive. Biofilm was
not observed on explants colonized with L. crispatus alone
at any time-point (data not shown).
Low pH inhibits growth of G. vaginalis and N.
gonorrhoeae on PVM
Lactic acid is thought to play a critical and complex role
in maintaining a healthy vaginal environment [23]. It is
thought that one important function of lactic acid is inhi-
biting the growth of potentially pathogenic organisms
including G. vaginalis and N. gonorrhoeae. Acetic acid is
produced by G. vaginalis and other anaerobes and high
levels of acetic acid in vaginal fluid are associated with BV
[53–56]. To determine if lactic acid, acetic acid or acidity
alone (using HCl) affect growth of the organisms under
study on the PVM model, culture media containing acids
at pH 7.0, 5.5 or 4.0 were produced and placed under
transwell membranes containing explants prior to inocu-
lation with various organisms. A reduction in pH with any
of the three acids tested had no affect on growth of L. cris-
patus at 48 h post-inoculation (Fig. 3a). In contrast, G.
vaginalis and N. gonorrhoeae were unable to grow on
PVM in the presence of media adjusted to pH 4.0 with all
three acids tested (Fig. 3b, c). Interestingly, while N. gonor-
rhoeae grew well over both lactic acid and HCl at pH 5.5,
it consistently grew poorly over acetic acid at pH 5.5,
regardless of inoculum.
L. crispatus produces lactic acid and inhibits growth of G.
vaginalis and N. gonorrhoeae on PVM
Lactobacillus spp. inhibit in vitro growth of G. vaginalis
and N. gonorrhoeae [20, 27, 57]. Co-colonization experi-
ments were performed to determine if L. crispatus affects
G. vaginalis and N. gonorrhoeae growth on PVM. Because
inhibition of growth of G. vaginalis and N. gonorrhoeae is
thought to rely in part on lactic acid production by vaginal
Lactobacillus spp., resulting in low pH, unbuffered RPMI
was initially used to maintain explants. PVM was inocu-
lated with L. crispatus for 48 h prior to addition of G. vagi-
nalis (all incubations were performed under anaerobic
conditions). Under these conditions, the pH of the media
under the transwells containing explants inoculated with
L. crispatus did not go below 6.0 (Fig. 4a) and growth of
G. vaginalis was only reduced by ~ ½ log (Fig. 4b).
It seemed likely that the relatively small number of
bacteria on each explant was insufficient to produce
enough lactic acid to lower the pH of the 1 ml of media
below the transwells to < 6.0. It was hypothesized that
Fig. 1 Growth of human clinical isolates on porcine vaginal mucosa (PVM). a PVM is obtained as large specimens (i) and 5 mm explants are trimmed
(ii) and placed mucosal side up in transwells over liquid media (iii, iv). “Air” refers to either an aerobic or anaerobic environment depending on the
experiment being performed. b L. crispatus, c G. vaginalis, and d N. gonorrhoeae were inoculated onto PVM explants at ~ 104 CFU/explant (dotted
lines). Explants were processed for CFU/explant at each time point to evaluate bacterial growth. Data was log10 transformed and plotted on a log scale
as the mean ± SD
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use of media previously “conditioned” by L. crispatus
would support meaningful pH changes in the presence
of L. crispatus. To test this hypothesis, L. crispatus
conditioned media (CM) produced by sterile filtering
overnight aerobic cultures (produced without shaking)
of L. crispatus (pH 4.0 – 4.5) was mixed with unbuffered
RPMI resulting in a pH of 5.5 – 6.0, which is permissible
for growth of G. vaginalis (Fig. 3). This allowed for test-
ing the ability of L. crispatus on PVM to lower the local
pH to that observed in the vagina of healthy human sub-
jects (~ pH 3.5 – 4.5) and inhibit growth of G. vaginalis.
After 48 h, L. crispatus lowered the pH of CM below
the transwells to 4.0, a pH that was maintained over the
course of the experiments (Fig. 5a). The CM below
transwells containing uninfected explants or those colo-
nized with G. vaginalis alone remained at pH 5.0 – 5.5.
When G. vaginalis was added to explants pre-inoculated
with L. crispatus, it failed to grow whereas G. vaginalis
placed on explants alone (over CM, pH 5.5) grew to
normal densities (Fig. 5b). The levels of D- and L-lactic
acid were significantly increased in CM under transwells
containing explants inoculated with L. crispatus but not
those that were uninfected or colonized with G. vagina-
lis alone (Fig. 5c, d). D-lactate levels produced by L. cris-
patus alone averaged 35.52 ± 10.55 mM and L-lactic acid
levels averaged 19.90 ± 2.22 mM over 5 experiments
(Fig. 5e). These data are in excellent agreement with
results showing that 60 mM lactic acid (D + L) was
required to lower the pH to 4.0 and inhibit growth of G.
vaginalis (Fig. 3b). It should be noted that the levels of
D- and L-lactic acid reported in the “CM” columns of
Fig. 5c and d are from overnight aerobic broth culture
(obtained without shaking). Further accumulation of D-
and L-lactic acid in this media (reported in Fig. 5c-e)
was achieved under anaerobic conditions on PVM.
To directly analyze the effect of L. crispatus on N.
gonorrhoeae growth, experiments were performed with
unbuffered RPMI that was adjusted to pH 5.5 with lactic
acid prior to inoculation. After 48 h, L. crispatus lowered
the pH of media below transwells to 5.0 and further low-
ered the pH to 4.5 by 96 h (Fig. 6a). When N. gonor-
rhoeae was added to explants pre-inoculated with L.
Fig. 2 G. vaginalis and N. gonorrhoeae form biofilm on PVM. Strains were inoculated onto PVM explants at ~ 104 CFU/explant and processed for
microscopy at indicated times. The LIVE/DEAD stain allows for imaging of both the mucosal epithelium and bacteria. Green cells are alive while red
cells are dead. a-d, i-l Uncolonized control (CNTL) tissue remains healthy throughout both experiments as evidenced by large green intact epithelial
cells. e-h By 48 h post-colonization, G. vaginalis (GV) forms a patchy biofilm that persists and spreads over time (anaerobic growth). m-p In just 24 h N.
gonorrhoeae (NG) forms a robust biofilm, which thickens and persists over time (aerobic growth). Epithelial cells that can be seen under and around
the NG biofilm are alive as evidenced by their green staining, while those on GV-colonized explants are dead (large red cells under the green biofilm).
Scale bars = 100 μm for all images
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crispatus, the organism failed to grow whereas N. gonor-
rhoeae placed on explants alone grew to normal levels
(Fig. 6b). The effect of L. crispatus CM on N. gonor-
rhoeae growth was also determined. After 48 h L. crispa-
tus lowered the pH of underlying CM to 4.5 and further
to pH 4.0 after 96 h (Fig. 6c). The CM below transwells
containing uninfected explants or those colonized with
N. gonorrhoeae alone remained at pH 5.5. Surprisingly,
N. gonorrhoeae did not survive over CM, even at an
otherwise permissible growth pH (5.5) and in the
absence of L. crispatus pre-inoculation (CFUs were zero
for N. gonorrhoeae alone over CM or with L. crispatus
over CM). The inability of N. gonorrhoeae to survive on
PVM in the presence of CM was observed with CM pro-
duced from anaerobic and aerobic L. crispatus cultures
obtained without shaking (Fig. 6d). Though the back-
ground media for CM (NYC + RPMI) did affect N.
gonorrhoeae growth on PVM, it was not bactericidal as
was observed with CM. These data indicate that L. cris-
patus 24-9-7 produces a factor in broth culture that kills
N. gonorrhoeae even when the pH is permissible for N.
gonorrhoeae growth.
Discussion
Our limited understanding of the interactions of microbes
and the importance of microbial structures such as biofilms
in affecting the health of the human female reproductive
system requires the development of predictive, biologically
complex models. The goal of the current study was to use
ex vivo PVM to model interactions of Lactobacillus with G.
vaginalis and N. gonorrhoeae. Lactobacillus spp., and G.
vaginalis colonize the human vagina, while N. gonorrhoeae
is an obligate human pathogen that preferentially infects
both the endo- and ectocervix [58–61]. The PVM is
Fig. 3 Various acids inhibit growth of G. vaginalis and N. gonorrhoeae on PVM. RPMI was pH-adjusted with lactic acid, acetic acid or hydrochloric
acid (HCl) and placed under transwells containing PVM explants. Bacteria were enumerated 48 h post-colonization. L. crispatus and G. vaginalis
were incubated anaerobically, while N. gonorrhoeae was incubated aerobically. a The low pH produced by each of the three acids has no effect
on growth of L. crispatus. b G. vaginalis growth is inhibited at pH 4.0 in the presence of all three acids. c N. gonorrhoeae growth peaked at pH 5.5
in the presence of lactic acid and HCl, while growth was inhibited at pH 5.5 in the presence of acetic acid. Asterisks indicate significant difference
from inoculum (dotted lines) (p < 0.0001)
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Fig. 4 Unbuffered RPMI does not support sufficient pH changes in the presence of L. crispatus on PVM. Unbuffered RPMI was placed under transwells
and relevant explants were inoculated with L. crispatus. After 48 h, relevant explants were inoculated with G. vaginalis. Experiments were performed
under anaerobic conditions and the pH of media below explants was monitored over time. a Media under uncolonized controls (CNTL) and those
colonized with G. vaginalis (GV) alone reached pH 6.5 while those colonized with L. crispatus (LC) alone or co-colonized with both organisms (LC + GV)
reached pH 6.0 (N = 4, n = 1). b The presence of L. crispatus had a statistically significant (asterisk, p < 0.016), yet minor effect on G. vaginalis growth.
Dotted line represents GV inoculum
Fig. 5 Conditioned media supports L. crispatus-induced pH changes, inhibiting growth of G. vaginalis on PVM. Media from overnight aerobic
broth culture of L. crispatus was sterile filtered and mixed with unbuffered RPMI to achieve pH 5.5. This conditioned media (CM) was placed
under transwells and relevant explants were inoculated with L. crispatus. After 48 h, relevant explants were inoculated with G. vaginalis. Experiments
were performed under anaerobic conditions and the pH of media below explants was monitored over time. a Media under uncolonized controls
(CNTL) and those colonized with G. vaginalis (GV) alone remained at pH 5.0 – 5.5 while those colonized with L. crispatus (LC) alone or co-colonized with
both organisms (LC + GV) were reduced to pH 4.0 (N = 6, n = 1). b The presence of L. crispatus inhibited G. vaginalis growth. Dotted line represents GV
inoculum. Asterisk indicates significant difference in growth between the two groups shown (p < 0.0001). c, d D- and L-lactate levels in the CM below
transwells from experiment (a) were analyzed at 96 h. CM below explants colonized with L. crispatus (LC and LC + GV) showed a significant increase in
lactic acid when compared with uncolonized controls (CM) and G. vaginalis (GV) alone (p < 0.0001). e A comparison of D- and L- lactate levels in CM
below LC alone infections shows that D-lactate is produced at ~2X the level of L-lactate (p < 0.002). (C-E) Data shown are combined (N = 5, n = 1)
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squamous epithelium similar to human vaginal and ecto-
cervical epithelia making it an ideal candidate for ex vivo
studies of these organisms. Human clinical isolates of
Lactobacillus spp., G. vaginalis, and N. gonorrhoeae, colo-
nized and grew on PVM to clinically relevant densities.
Lactobacillus spp. grew to ~ 1.0 x 107 CFU/ml, which is in
accordance with published findings of 103 – 109 CFU/ml in
vaginal specimens [62, 63]. Growth of G. vaginalis on PVM
(~1.3 x 108 CFU/ml) mimics the densities found during BV,
as women without BV are colonized by < 2 x 107 CFU/ml,
while those with BV are colonized by > 2 x 107 CFU/ml
[64]. N. gonorrhoeae grew to ~ 4.2 x 107 CFU/ml, which is
slightly higher than the reported range of 5 x 103 – 8 x
106 CFU/ml obtained from vaginal washes [65]. These data
demonstrate that the observed growth of human clinical
bacterial isolates on PVM reflects the number of organisms
found in human vaginal fluids/washes. Investigations of
temporal dynamics on PVM are limited though as growth
of the organisms under study generally peaked at 48 – 72 h
post-colonization and waned at later time points, likely due
to depletion of nutrients in this closed system.
Both G. vaginalis and N. gonorrhoeae form robust bio-
films on PVM. Multiple lines of evidence suggest that
biofilm formation by G. vaginalis strains in vivo is a crit-
ical first step in the development and recurrence of BV
[66, 67]. Additionally, evidence suggests that the ability
of any particular strain to form a biofilm may be a key
factor in distinguishing pathogenic G. vaginalis from
commensal strains found in many asymptomatic women
[68]. The G. vaginalis strain used in this study (ATCC
14018) produces a cholesterol-dependent cytolysin
(CDC), vaginolysin (VLY) [69, 70] that lyses cervical epi-
thelial cells [71]. PVM colonized with G. vaginalis bio-
film showed extensive epithelial cell death, suggesting
that VLY might be active in this system. The Staphylo-
coccus aureus cytolysin α-toxin is required for biofilm
formation on PVM [36] while the Streptococcus pneu-
moniae CDC, pneumolysin, is not required for biofilm
formation in a mouse nasopharyngeal colonization
model [72]. It will be interesting to determine if VLY is
required for biofilm formation ex vivo and what role
lysis versus epithelial cell signaling may play in the VLY
Fig. 6 L. crispatus inhibits growth of N. gonorrhoeae. a, b Unbuffered RPMI or (c) L. crispatus CM was adjusted to pH 5.5 and placed under
transwells. Relevant explants were inoculated with L. crispatus. After 48 h, relevant explants were inoculated with N. gonorrhoeae. Experiments
were performed under aerobic conditions and the pH of media below explants was monitored over time. a RPMI under uncolonized controls
(CNTL) and those colonized with N. gonorrhoeae (NG) alone remained at pH 5.5 while RPMI under explants colonized with L. crispatus (LC) alone
or co-colonized with both organisms (LC + NG) was reduced to pH 4.5 (N = 4, n = 1). b The presence of L. crispatus inhibited 48 h N. gonorrhoeae
growth. Asterisk indicates significant difference in growth between the two groups shown (p < 0.002). c CM under CNTL or NG remains at pH 5.5
while CM under explants colonized with LC alone or co-colonized with both organisms (LC + NG) was reduced to pH 4.0 (N = 3, n = 1). d While N.
gonorrhoeae did exhibit a growth defect over NYC + RPMI media (the background media for CM) it was completely killed by aerobic or anaerobic
CM at pH 5.5, even in the absence of a L. crispatus co-infection. Asterisks indicate significant difference from inoculum (p < 0.0001). For (b) and
(d), dotted lines represent NG inocula
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contribution to G. vaginalis colonization and/or biofilm
formation [69]. Because G. vaginalis is a genomically
diverse species, other factors might be important in
determining characteristics necessary for pathogenicity
[73]. Future experiments will explore the molecular
mechanisms used by G. vaginalis, and N. gonorrhoeae
to form biofilm on PVM and the ability of Lactobacillus
spp. and their secreted products to prevent/disrupt
these biofilms.
Vaginal pH increases in women with BV and may be
associated with STI susceptibility. It is becoming evident
that lactic acid produced by Lactobacillus spp. contrib-
utes to overall vaginal health and inhibition of growth of
pathogenic organisms in vitro [21, 23, 74]. BV-associated
organisms, including G. vaginalis, produce acetic acid
and there is a loss of lactic acid production and an in-
crease in acetic acid in the vaginal fluid of women with
BV [53, 56]. Of the three acids tested, lactic acid consist-
ently showed a much larger degree of killing G. vaginalis
at pH 4.0. It may be that lactic acid has a specific bac-
tericidal affect on G. vaginalis but it is unclear if this
affect is necessary to keep G. vaginalis growth in check,
or if the effects of low pH alone are sufficient to do so.
Co-colonization experiments with L. crispatus and G.
vaginalis on PVM (anaerobic) clearly showed an associ-
ation between lactic acid production, a reduction in the
local pH, and inhibition of G. vaginalis growth. These
results reflect previous observations that under anaer-
obic conditions (where H2O2 is minimally produced),
lactic acid inhibits growth of G. vaginalis (and other BV-
associated organisms) in vitro [26]. The results here
show that L. crispatus inhibition of G. vaginalis growth
is pH-dependent; lactic acid production is not sufficient
to inhibit G. vaginalis growth if it is not accompanied by
a reduction in pH. L. crispatus produced higher levels of
D- versus L-lactate, as previously reported for the spe-
cies [75]. The differential production of D- and L-lactate
by various Lactobacillus spp. may be important in influ-
encing host responses and susceptibility to BV and future
work will tease out these differences by expanding the
species and strains used in co-infection experiments.
Women with Lactobacillus-dominated vaginal micro-
biota are less susceptible to N. gonorrhoeae infection
[16, 19, 20]. The mechanism of inhibition of N. gonor-
rhoeae by Lactobacillus spp. is unclear as multiple studies
demonstrate that lactic acid, H2O2, and Lactobacillus bacte-
riocins can inhibit N. gonorrhoeae growth in vitro depend-
ing on the growth conditions. Though lactic acid alone at
pH 5.5 was permissible for N. gonorrhoeae growth, L.
crispatus anaerobic CM at pH 5.5 was not, indicating
that this L. crispatus strain produces a factor other than
lactic acid that inhibits N. gonorrhoeae growth. This
data also supports the hypothesis that H2O2 does not
likely play an inhibitory role in vivo, as H2O2 is
undetectable in Lactobacillus broth culture incubated
anaerobically and in cervicovaginal fluid [25, 76].
PVM represents a biologically relevant model that
cannot only be used to ask fundamental questions about
microbial interactions, but also help translate new tech-
nologies to clinical use. While it is likely that some host/
bacterial interactions are not identical between the
porcine and human mucosal epithelia, PVM has proven
to be useful in assessing host toxicity of potential antimi-
crobials and is predictive of clinical efficacy [38, 77]. The
use of probiotic Lactobacillus spp. has been investigated
as a prevention of and treatment for BV [78]. The PVM
model used in this study could be used to screen poten-
tial probiotic organisms for their ability to prevent the
growth of a variety of BV-associated organisms and
decipher the mechanisms of inhibition. Advantages of
PVM include that it is not subject to regulation as live
animal models are, it is inexpensive, relatively easy to
obtain and semi-high throughput. This model is poten-
tially an excellent platform for initial testing of novel ther-
apeutics against STIs, such as drug-resistant strains of N.
gonorrhoeae. Importantly, toxic effects of new drugs on
the host mucosa and resident protective microbes such as
Lactobacillus spp. could also be investigated with the
PVM model.
Future work will include investigations of the mecha-
nisms of biofilm formation, Lactobacillus spp. interactions
with BV-associated organisms and STI agents, the host
response to colonization and the efficacy of antimicrobials
against STIs using the PVM model.
Conclusions
An acidic environment (pH <4.5) inhibits colonization
of live vaginal mucosa by both G. vaginalis and N.
gonorrhoeae regardless of the acid tested. N. gonorrhoeae
grows best in the presence of lactic acid at pH 5.5 per-
haps contributing to increased susceptibility during BV.
Additionally, a high concentration of acetic acid inhibits
N. gonorrhoeae growth on PVM at pH 5.5. A stable L.
crispatus colonization of live vaginal mucosa is able to
prevent colonization of G. vaginalis in a pH-dependent
manner, while L. crispatus secretes a factor that kills N.
gonorrhoeae. The PVM model will continue to be used
to investigate these interactions and the mechanisms of
G. vaginalis and N. gonorrhoeae biofilm formation on
live vaginal tissue.
Methods
Bacterial isolates and culture conditions
L. crispatus, L. jensenii, L. gasseri and L. iners were
isolated from vaginal swabs of reproductive age, asymp-
tomatic women who were not menstruating at the time
of collection. These isolates were collected as part of
broader longitudinal genomic studies of the vaginal
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microbiome [79, 80]. The clinical study protocols were ap-
proved by the Institutional Review Boards of the Johns
Hopkins University School of Medicine, the University of
Maryland School of Medicine and the University of
Alabama at Birmingham. Written informed consent was
obtained from all participants. The L. crispatus isolate used
in the current study was designated 24-9-7 and was isolated
from a woman who was dominated with L. crispatus each
day of the 10-week sampling period except during menses
when the community shifted and L. iners was dominant. G.
vaginalis is a clinical isolate obtained from ATCC (14018).
G. vaginalis and Lactobacillus spp. were cultured in New
York City III (NYC III) media (10 g/L proteose peptone,
10 g/l beef extract, 5 g/l yeast extract, 5 g/L NaCl, 1.2 g/L
MgSO4, 2 g/L MnSO4 ∙ H2O, 5.7 g/L K2HPO4, 20 g/L glu-
cose, 10 % fetal bovine serum [FBS]) overnight anaerobic-
ally at 37 °C without shaking and diluted 1:10 or 1:100 just
prior to inoculation. N. gonorrhoeae strain 23482 is a clin-
ical isolate from male urethral source obtained from the
Minnesota Department of Health. Bacteria from a freshly
streaked modified Thayer-martin (MTM) agar plate (VWR,
90006–270) were scrapped into 1 ml of media followed by
vortexing and diluting 1:100 for immediate use as N. gonor-
rhoeae inocula. Anaerobic conditions (<1.0 % O2, > 13 %
CO2) for relevant experiments were achieved using the
GasPak system (BD Biosciences, 260672, 260001). A spiral
plater (Biotek, Microbiology International) was used
for enumeration of CFUs. Lactobacillus spp. and G.
vaginalis were plated on tryptic soy agar containing
5 % sheep’s blood (Fisher, B11947) and N. gonor-
rhoeae was plated on MTM agar.
Ex vivo porcine vaginal mucosa
Specimens of normal porcine vaginal mucosa (PVM) are
excised from mature (6 months), animals at slaughter in
the University of Minnesota Andrew Boss Laboratory of
Meat Science and transported to the laboratory in
antibiotic-free RPMI 1640 (Gibco) with 10 % fetal calf
serum. The vaginal tissue is a by-product of the slaugh-
ter of animals for human consumption and therefore is
Institutional Animal Care and Use Committee (IACUC)
exempt. Tissue was utilized within 3 h of excision.
Explants of uniform size were obtained using a 5 mm
biopsy punch and excess muscle was trimmed away with
a scalpel. Explants were sterilized via 1 min incubation
with 10 % povidone-iodine (PI) (Alfa Aesar, 45782). The
explants were rinsed once with 10 ml standard sampling
solution (3 mM KH2PO4, 71 mM Na2HPO4, 0.1 %
Triton X-100, 3 % Tween 80, 3 g/L lecithin, 4 mM
Na2S2O3 ∙ 5H2O) to neutralize PI and three times with
10 ml RPMI and placed mucosal side up on a PET
track-etched 0.4 mm cell culture insert (Fisher, 0877115)
in 6-well plates containing 1 ml of indicated media
below inserts. The mucosal surface was continually
exposed to the aerobic or anaerobic environment.
For bacterial colonization of PVM, explants were inoc-
ulated with ~104 CFU/explant. Lactobacillus spp. and G.
vaginalis were incubated anaerobically while N. gonor-
rhoeae was incubated aerobically on explants for indi-
cated times at 37 °C. Explants were vortexed in 250 μl
PBS for 4 min at max speed to release bacteria for
analysis of CFU/explant and CFU/ml.
To determine the effects of various acids on bacterial
growth: lactic acid (Sigma, 69785) was used at 15 mM
(pH 7.0), 30 mM (pH 5.5) or 60 mM (pH 4.0); acetic
acid was used at 20 mM (pH 7.0), 100 mM (pH 5.5) or
750 mM (pH 4.0); hydrochloric acid (HCl) was used at
5 mM (pH 7.0), 15 mM pH 5.5) or 40 mM (pH 4.0). To
achieve RPMI at pH 7.0 for each acid, the acids were
added to RPMI at the indicated molarity and the solu-
tion pH-adjusted with NaOH. Explants were inoculated
with ~104 CFU/explant and incubated for 48 h at 37 °C
over indicated media. L. crispatus and G. vaginalis
were incubated anaerobically while N. gonorrhoeae
were incubated aerobically. Explants were then proc-
essed as above.
For co-colonization experiments, overnight cultures of
L. crispatus (pH 4.0) were sterile filtered (0.45 μm) to
produce conditioned media (CM). CM was diluted by ~ ½
with unbuffered RPMI 1640 (GIBCO, 11875–093) to
reach pH 6.0 – 5.5. As indicated in figures, either RPMI +
CM, RPMI + lactic acid or unbuffered RPMI was used for
each experiment. Explants were washed for 30 min in
relevant media and placed in transwells over 1 ml of
corresponding media. Explants were inoculated with ~104
L. crispatus CFU/explant and incubated anaerobically for
48 h at 37 °C. Explants were then inoculated with ~104G.
vaginalis or N. gonorrhoeae CFU/explant and incubated
anaerobically or aerobically, respectively, for 48 h. Ex-
plants were processed as above for CFU analysis. The
pH of the underlying media was recorded at 0 h,
48 h and 96 h.
Analysis of lactic acid production
The media below transwells used in the L. crispatus/G.
vaginalis co-colonization experiments described above
were collected at the end of the experiment (96 h) and
stored at 4 °C for further analysis. Levels of D- and L- lactic
acid in the media were assessed using a lactate quantifica-
tion assay kit according to the manufacturer’s instructions
(BioAssay Systems, EFDLC-100 and EFLLC-100).
Biofilm microscopy
Uninfected and PVM explants colonized with various
bacterial strains and incubated for 24 – 96 h at 37 °C
were stained using the LIVE/DEAD Biofilm Viability kit
(Invitrogen, L10316) according to instructions. Explants
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were washed three times with 1 ml/well in Hank’s
balanced salt solution (Life Technologies, 14185052) and
transferred to glass slides. A 1 mm spacer (Electron
Microscopy Sciences, 70327–10) with a glass coverslip was
placed over the explants. The epithelial surface of the
explants was imaged with a Nikon Ni-E confocal micro-
scope using a 60X oil immersion objective. Images were
captured and processed using the Nikon NIS Elements soft-
ware. Imaging was performed at the University Imaging
Centers at the University of Minnesota.
Statistical analysis
All data shown are representative of at least 3 independent
experiments with at least 3 replicates (N ≥ 3, n ≥ 3) unless
otherwise noted. Graphs were produced and statistical
analysis performed using the Prism software (GraphPad).
Statistical differences were determined using either One-
Way ANOVA (with Dunnett’s multiple comparison test) or
(when only two conditions were being compared)
Student’s t-test.
Availability of supporting data
The data set(s) supporting the results of this article is (are)
included within the article (and its additional file(s)).
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